2. Bronchiectasis
Definition
Bronchiectasis is an irreversible abnormal dilatation of the bronchi due to chronic infection and inflammation, resulting in impaired mucus clearance and persistent cough with sputum production.
π― EXAM ANCHOR β CORE CONCEPT (PARA)
- Bronchiectasis = irreversible bronchial dilatation
- Driven by chronic infection and inflammation
- Hallmark symptom = persistent productive cough
- Β
π PARA commonly asks:
A patient has irreversible airflow obstruction with daily productive cough and recurrent chest infections. What underlying structural abnormality explains this?
π‘ PARA Differentiation Tip
COPD β irreversible airflow obstruction due to smoking-related airway/alveolar damage
Bronchiectasis β irreversible airflow obstruction due to structural airway dilatation + sputum
π§ PARA Memory Trigger
βWet lungs every dayβ β think bronchiectasis, not COPD or asthma
Pathophysiology
Mnemonic: CYCLE
Chronic infection β
Yielding inflammation
Ciliary damage
Loss of airway tone
Expansion of bronchi (permanent dilatation)
β Leads to mucus stasis, colonisation, and recurrent infections.
π Causes
π§ Mnemonic: ABCD SHIRT
Abnormal cilia (e.g. Kartagener’s, PCD)
Bronchial obstruction (tumour, foreign body)
Cystic Fibrosis
Deficiency (immune β IgA, IgG)
Systemic disease (RA, IBD, Sjogrenβs)
Hypersensitivity (ABPA β allergic bronchopulmonary aspergillosis)
Infection (childhood measles, TB, pertussis)
Reflux/aspiration
Tuberculosis or other granulomatous infection
Clinical Features
Mnemonic: COUGH SPIT
-
Chronic productive cough
-
Overproduction of sputum (purulent, foul-smelling)
-
Up to 2+ exacerbations per year
-
Green/yellow mucus plugs
-
Haemoptysis (mild to massive)
-
Shortness of breath
-
Pleuritic chest pain
-
Infections recurrent
-
Tiredness (systemic symptoms)
π©ΊPhysical Examination Findings
Bilateral coarse crackles Β± wheeze
Clubbing
Signs of underlying cause (e.g. nasal polyps in CF, rash in vasculitis)
π¬ Investigation Ladder for Bronchiectasis
1οΈβ£ First-line Investigations (Initial Assessment)
| Test | Why / Exam Notes |
|---|---|
| CXR | May be normal; tram-track lines, ring shadows |
| Spirometry | Obstructive pattern (βFEVβ, βFEVβ/FVC, little/no reversibility). Helps distinguish from asthma. |
| Sputum culture | Essential before antibiotics. Common bugs: H. influenzae, Pseudomonas, Staph aureus. |
π― EXAM ANCHOR 2 β ASTHMA / COPD DIFFERENTIATION
Asthma β reversible obstruction
Bronchiectasis β obstructive pattern with little/no reversibility
Chronic productive cough is key discriminator
π PARA commonly asks:
Which feature best differentiates bronchiectasis from asthma?
2οΈβ£ Second-line (Diagnostic Confirmation)
| Test | Why / Exam Notes |
|---|---|
| High-resolution CT (HRCT) | Gold standard |
| Β | Tram-track sign |
| Β | Signet-ring sign (Internal bronchial diameter > its accompanying pulmonary artery.) |
| Β | Cystic dilatation |
EXAM ANCHOR 3 β DIAGNOSIS (GOLD STANDARD)
High-resolution CT (HRCT) = diagnostic gold standard
Key CT signs:
Tram-track sign
Signet-ring sign
Cystic bronchial dilatation
CXR may be normal and does not exclude bronchiectasis
PARA commonly asks:
Which investigation confirms bronchiectasis?
3οΈβ£ Third Line (Identify Underlying Cause)
| Test | Purpose |
|---|---|
| Immunoglobulins (IgA, IgG, IgM) | Detect immune deficiency. |
| Sweat test Β± CFTR genetics | Rule out Cystic Fibrosis in young/adult-onset cases. |
| Aspergillus IgE / precipitins | DiagnoseΒ Allergic Bronchopulmonary Aspergillosis (ABPA) |
| Autoimmune screen (ANCA, RF) | If vasculitis/systemic disease suspected (e.g. GPA, RA, IBD). |
| HIV | If immunosuppression suspected. |
4οΈβ£ Targeted / Specialist Investigations
| Test | Indication |
|---|---|
| Bronchoscopy | Focal disease β exclude obstruction |
| Baseline bloods | Safety for long-term therapy |
5οΈβ£ Advanced / Specialist Care
| Intervention | Indication |
|---|---|
| Surgical resection | Localised severe disease |
| Lung transplant | End-stage disease |
π Management Ladder for Bronchiectasis
1οΈβ£ First-line (all patients)
| Intervention | Key Notes |
|---|---|
| Airway clearance physiotherapy | Chest physio + postural drainage = cornerstone of management. Daily routine. |
| Smoking cessation + vaccinations | Flu + pneumococcal essential. |
| Treat underlying cause | e.g. stop aspiration, treat immune deficiency, ABPA, CF. |
EXAM ANCHOR 4 β FIRST-LINE MANAGEMENT LONG TERM MANAGEMENT
First-line management includes Active Cycle of Breathing Techniques (ACBT) and checking/supplementing Vitamin D levels.
Antibiotics alone are not sufficient long-term management
Vaccinations + smoking cessation are mandatory supportive care
PARA commonly asks:
Most important long-term management strategy in bronchiectasis?
Answer: Airway clearance physiotherapy
2οΈβ£ During Exacerbation
| Intervention | Key Notes |
|---|---|
| 14-day antibiotics (oral, guided by sputum culture) | Empirical if no result: amoxicillin (or doxycycline/clarithromycin if penicillin-allergic). Pseudomonas β ciprofloxacin. |
| Sputum culture at each exacerbation | Guides therapy + resistance monitoring. |
EXAM ANCHOR 5 β EXACERBATIONS
Always send sputum culture before antibiotics
Treat exacerbations withΒ 14-day antibiotics
If Pseudomonas aeruginosa is isolated for the first-time, NICE recommends eradication therapy (specialist-led) rather than standard symptom management.
PARA commonly asks:
Best next step in an acute exacerbation?
3οΈβ£ Long-term / frequent exacerbators
| Intervention | Key Notes |
|---|---|
| Long-term macrolides (azithromycin 3x/week) | If β₯3 exacerbations/year. Reduces exacerbation frequency. |
| Inhaled antibiotics (colistin, tobramycin) | For chronic Pseudomonas colonisation. Specialist-led. |
EXAM ANCHOR 6 β FREQUENT EXACERBATORS
β₯3 exacerbations/year β consider long-term macrolide
Before starting long-term macrolides (Azithromycin), you must perform:
Sputum culture for NTM (Non-Tuberculous Mycobacteria) to prevent resistance.
Baseline ECG to check the QTc interval (Macrolides can prolong QTc).
Chronic Pseudomonas colonisation β inhaled antibiotics
Specialist supervision required
PARA commonly asks:
Indication for long-term antibiotics in bronchiectasis?
4οΈβ£ Adjunctive therapy
| Intervention | Key Notes |
|---|---|
| Mucolytics (e.g. carbocisteine) | May help sputum clearance. |
| Bronchodilators | If asthma/COPD overlap or reversible obstruction. |
5οΈβ£ Specialist referral / advanced care
| Intervention | Indication |
|---|---|
| Surgical resection (lobectomy) | Rare β for localised, severe, resistant disease. |
| Lung transplant | End-stage bronchiectasis with severe respiratory failure. |
β οΈ Complications
Respiratory failure
Massive haemoptysis
Pseudomonas colonisation
Pulmonary hypertension
Cor pulmonale
ABPA (allergic bronchopulmonary aspergillosis)
π― EXAM ANCHOR 7 β HAEMOPTYSIS (HIGH-RISK TRAP)
Mild haemoptysis = common
Massive haemoptysis = medical emergency
Requires urgent admission Β± interventional radiology
π PARA commonly asks:
Which complication requires urgent escalation?
π§Differentials
Mnemonic: CHAPS
-
COPD
-
Haemoptysis from TB/lung cancer
-
Asthma
-
Pneumonia
-
Sinusitis/post-nasal drip
Key PARA Exam Traps
HRCT is gold standard β tram-track sign, ring shadows
Always send sputum culture, especially in exacerbations
Cough + sputum + coarse crackles = high yield
Daily chest physio is first-line long term management
Long-term abx for frequent exacerbators
π Last updated in line with NICE NG117 β Bronchiectasis
Published: December 2018 β’ Last updated: February 2024
Last reviewed: February 2026
π PASSMAP ensures all content is NICE-aligned and reviewed for Physician Associate Registration Assessment (PARA) success.
Β
Educational platform. Not medical advice.
Β
